Indian economy is transforming, offering opportunities for Non-Resident Indians. Despite rupee depreciation, an undervalued currency presen...

A peace deal, if it comes, will not mean the Gulf region has become stable. It will only mean that current tensions have been paused. The k...

The Indian rupee strengthened to a six-week high, buoyed by falling Brent crude prices below $80 a barrel and supportive central bank measu...

India's long-term growth outlook remains robust despite global geopolitical uncertainties and intermittent market volatility, supported by ...

Global markets are cautiously optimistic about a potential US-Iran agreement easing geopolitical risks and crude oil volatility. However, I...

Despite record FII outflows from Indian equities since September 2024, Jefferies said India remains a consensus underweight among emerging ...

Indian equities offer rare discounts for investors. Nippon India Mutual Fund's Equity CIO, Sailesh Raj Bhan, advises accumulating world-cla...

Indian equities surged nearly 1% as bulls charged through Dalal Street, driven by an Iran-US peace framework and sliding oil prices. The Se...

SpaceX's massive IPO is making waves globally. However, Indian market experts believe this will not directly impact upcoming listings of Ji...

Foreign investors continue to sell Indian shares. They have withdrawn over Rs 62,853 crore in early June. This follows significant outflows...

Manish Banthia, CIO-Fixed Income at ICICI Prudential AMC, who correctly predicted the gold rally in 2023, now sees little value in adding f...

Sectoral and thematic mutual fund inflows saw a significant drop in May, falling by 67%. This decline suggests investors are moving away fr...

Foreign investors have significantly reduced holdings in many Nifty companies since September 2024. This has impacted top blue-chip stocks,...

India's IPO arena is poised for dynamic growth, with a wave of businesses on the brink of launching their public shares, fueled by an incre...

Citi Research lowered its Nifty target due to rising earnings risks linked to geopolitical tensions and other macro concerns. However, it r...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Morgan Stanley remains bullish on Indian equities, citing an earnings upcycle, supportive macroeconomic conditions and strong domestic flow...